<?xml version="1.0" encoding="UTF-8"?>
<p id="par0100">There are still no data on a maternal SARS-CoV-2 infection in the 1 st and 2nd trimester of pregnancy, including the risk of early miscarriage, fetal death in utero and growth retardation. A single study do not find viral RNA in amniotic fluid in mid-pregnancy on two patients exposed in the first trimester [
 <xref rid="bib0215" ref-type="bibr">43</xref>]. A study published in 2004 during the SARS epidemic found a higher rate of miscarriage, premature delivery and stunting, but no argument for vertical transmission [
 <xref rid="bib0220" ref-type="bibr">44</xref>]. In addition, abnormally high mortality was not observed in pregnant women infected with SARS-CoV-2, compared to what had been observed during the epidemics SARS-CoV-1 and MERS-CoV [
 <xref rid="bib0225" ref-type="bibr">45</xref>]. No fetopathy has been described to date in fetuses or neonates whose mothers had COVID-19.
</p>
